TFF3 expression at the esophagogastric junction is increased in gastro-esophageal reflux disease (GERD)

Peptides

Volumn 25, Issue 5, 2004, Pages 771-777

  Peitz, Ulrich ^a   Kouznetsova, Irina ^a   Wex, Thomas ^a   Gebert, Ingrid ^a   Vieth, Michael ^a   Roessner, Albert ^a   Hoffmann, Werner ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Esophagogastric junction; Gastro esophageal reflux disease; Helicobacter pylori; Intestinal metaplasia; TFF domain; Trefoil factor

Indexed keywords

INTERLEUKIN 8; TREFOIL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CARDIA; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENDOSCOPIC BIOPSY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BARRETT ESOPHAGUS; CARDIA; ESOPHAGOGASTRIC JUNCTION; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; MUCINS; MUSCLE PROTEINS; PEPTIDES; PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

HELICOBACTER; HELICOBACTER PYLORI; LOTUS;

EID: 2642551341     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.01.018     Document Type: Article

References (43)

1. Arul G.S., Moorghen M., Myerscough N., Alderson D.A., Spicer R.D., Corfield A.P. Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut. 47:2000;753-761
2. Chandrasoma P.T., Der R., Dalton P., Kobayashi G., Ma Y., Peters J., et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am. J. Surg. Pathol. 25:2001;1188-1193
3. Chandrasoma P.T., Der R., Ma Y., Dalton P., Taira M. Histology of the gastroesophageal junction: an autopsy study. Am. J. Surg. Pathol. 24:2000;402-409
4. Chandrasoma P.T., Der R., Ma Y., Peters J., Demeester T. Histologic classification of patients based on mapping biopsies of the gastroesophageal junction. Am. J. Surg. Pathol. 27:2003;929-936
5. Chandrasoma P.T., Lokuhetty D.M., Demeester T.R., Bremmer C.G., Peters J.H., Oberg S., et al. Definition of histopathologic changes in gastroesophageal reflux disease. Am. J. Surg. Pathol. 24:2000;344-351
6. Devesa S.S., Blot W.J., Fraumeni J.F. Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049-2053
7. Eloubeidi M.A., Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am. J. Gastroenterol. 94:1999;937-943
8. Falk G.W. Barrett's esophagus. Gastroenterology. 122:2002;1569-1591
9. Fitzgerald R.C., Farthing M.J. The pathogenesis of Barrett's esophagus. Gastrointest. Endosc. Clin. N. Am. 13:2003;233-255
10. Fitzgerald R.C., Onwuegbusi B.A., Bajaj-Elliott M., Saeed I.T., Burnham W.R., Farthing M.J. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut. 50:2002;451-459
11. Glickman J.N., Fox V., Antonioli D.A., Wang H.H., Odze R.D. Morphology of the cardia and significance of carditis in pediatric patients. Am. J. Surg. Pathol. 26:2002;1032-1039
12. Hackelsberger A., Gunther T., Schultze V., Manes G., Dominguez-Munoz J.E., Roessner A., et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut. 43:1998;17-21
13. Hanby A.M., Jankowski J.A., Elia G., Poulsom R., Wright N.A. Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: delineation of epithelial phenotype. J. Pathol. 173:1994;213-219
14. Hauser F., Poulsom R., Chinery R., Rogers L.A., Hanby A.M., Wright N.A., et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6961-6965
15. Hoffmann W., Jagla W. Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int. Rev. Cytol. 213:2002;147-181
16. Hoffmann W., Jagla W., Wiede A. Molecular medicine of TFF-peptides: from gut to brain. Histol. Histopathol. 16:2001;319-334
17. Jankowski J.A., Harrison R.F., Perry I., Balkwill F., Tselepis C. Barrett's metaplasia. Lancet. 356:2000;2079-2085
18. Kilgore S.P., Ormsby A.H., Gramlich T.L., Rice T.W., Richter J.E., Falk G.W., et al. The gastric cardia: fact or fiction? Am. J. Gastroenterol. 95:2000;921-924
19. Labouvie C., Machado J.C., Carneiro F., Sarbia M., Vieth M., Porschen R., et al. Differential expression of mucins and trefoil peptides in native epithelium. Barrett's metaplasia and squamous cell carcinoma of the oesophagus. J. Cancer Res. Clin. Oncol. 125:1999;71-76
20. Leung W.K., Sung J.J. Intestinal metaplasia and gastric carcinogenesis. Aliment. Pharmacol. Ther. 16:2002;1209-1216. [Review]
21. Leung W.K., Yu J., Chan F.K., To K.F., Chan M.W., Ebert M.P., et al. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J. Pathol. 197:2002;582-588
22. Longman R.J., Douthwaite J., Sylvester P.A., Poulsom R., Corfield A.P., Thomas M.G., et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut. 47:2000;792-800
23. McClave S.A., Boyce H.W. Jr., Gottfried M.R. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest. Endosc. 33:1987;413-416
24. Meining A., Morgner A., Miehlke S., Bayerdorffer E., Stolte M. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract. Res. Clin. Gastroenterol. 15:2001;983-998
25. Oberg S., Peters J.H., Demeester T.R., Chandrasoma P., Hagen J.A., Ireland A.P., et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann. Surg. 226:1997;522-530
26. Paull A., Trier J.S., Dalton M.D., Camp R.C., Loeb P., Goyal R.K. The histologic spectrum of Barrett's esophagus. N. Engl. J. Med. 295:1976;476-480
27. Podolsky D.K., Lynch-Devaney K., Stow J.L., Oates P., Murgue B., De Beaumont M., et al. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J. Biol. Chem. 268:1993;675-680
28. Redel CA. Anatomy, histology, embryology, and developmental anomalies of the stomach and duodenum. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, Vol. 1; 7th edition. Philadephia, Saunders; 2003, pp. 675-90.
29. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am. J. Gastroenterol. 97:2002;1888-1895
30. Shaheen N.J., Crosby M.A., Bozymski E.M., Sandler R.S. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology. 119:2000;333-338
31. Shimoyama T., Crabtree J.E. Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut. 43(Suppl. 1):1998;S2-S5
32. Spechler S.J. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology. 117:1999;218-228
33. Spechler S.J., Zeroogian J.M., Antonioli D.A., Wang H.H., Goyal R.K. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 344:1994;1533-1536
34. Taupin D., Pedersen J., Familari M., Cook G., Yeomans N., Giraud A.S. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab. Invest. 81:2001;397-408
35. Van De Bovenkamp J.H., Korteland-Van Male A.M., Warson C., Buller H.A., Einerhand A.W., Ectors N.L., et al. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2. Histopathology. 42:2003;555-565
36. Voutilainen M., Farkkila M., Juhola M., Mecklin J.P., Sipponen P. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut. 45:1999;644-648
37. Warson C., Van De Bovenkamp J.H., Korteland-Van Male A.M., Buller H.A., Einerhand A.W., Ectors N.L., et al. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Hum. Pathol. 33:2002;660-668
38. Wex T., Treiber G., Lendeckel U., Malfertheiner P. A two-step method for the extraction of high-quality RNA from endoscopic biopsies. Clin. Chem. Lab. Med. 41:2003;1033-1037
39. Wiede A., Hinz M., Canzler E., Franke K., Quednow C., Hoffmann W. Synthesis and localization of the mucin-associated TFF-peptides in the human uterus. Cell Tissue Res. 303:2001;109-115
40. Wong W.M., Poulsom R., Wright N.A. Trefoil peptides. Gut. 44:1999;890-895
41. Wright N.A. Aspects of the biology of regeneration and repair in the human gastrointestinal tract. Philos. Trans. R. Soc. Lond. B Biol. Sci. 353:1998;925-933
42. Wright N.A., Pike C., Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 343:1990;82-85
43. Yamachika T., Werther J.L., Bodian C., Babyatsky M., Tatematsu M., Yamamura Y., et al. Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma. Clin. Cancer Res. 8:2002;1092-1099